Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study

AIMS: To report 1-year clinical and economic outcomes from the retrospective DISPEL (Dulaglutide vs Basal InSulin in Injection Naïve Patients with Type 2 Diabetes: Effectiveness in ReaL World) Study. MATERIALS AND METHODS: This observational claims study included patients with type 2 diabetes (T2D)...

Descripción completa

Detalles Bibliográficos
Autores principales: Mody, Reema, Huang, Qing, Yu, Maria, Patel, Hiren, Zhang, Xian, Wang, Liya, Grabner, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Emerging technology, pharmacology and Therapetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904197/
https://www.ncbi.nlm.nih.gov/pubmed/31875137
http://dx.doi.org/10.1136/bmjdrc-2019-000884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904197/
https://www.ncbi.nlm.nih.gov/pubmed/31875137
http://dx.doi.org/10.1136/bmjdrc-2019-000884

Ejemplares similares